Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin, Etoposide, and Bevacizumab in Previously Untreated Extensive Stage Small Cell Lung Cancer
NCT00079040Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2006
- Primary completion
- Jan 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in small cell lung cancer (SCLC), sponsored by National Cancer Institute. Started Jan 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00079040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079040.